Innovative Use of Biotrace Tempo Pacemaker Lead Following Cardiac Surgery

Authors

Jordan E Goldhammer, Thomas Jefferson UniversityFollow
Regina E Linganna, Thomas Jefferson UniversityFollow
Douglas S Pfeil, Thomas Jefferson UniversityFollow
Scott D Witzeling, Thomas Jefferson UniversityFollow
Alec Vishnevsky, Thomas Jefferson UniversityFollow
Nicholas Ruggiero, Thomas Jefferson UniversityFollow
T. Sloane Guy, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

7-1-2022

Comments

This article is the author’s final published version in Annals of Cardiac Anaesthesia, Volume 25, Issue 3, July 2022, Pages 362 - 365.

The published version is available at https://doi.org/10.4103/aca.aca_25_22. Copyright © 2022 Wolters Kluwer Medknow Publications. All rights reserved.

Abstract

The Tempo® Temporary Pacing Lead is a temporary, transvenous, active fixation pacemaker lead used exclusively in structural heart and electrophysiology procedures since regulatory approval in 2016. We utilized the Tempo lead for four patients undergoing redo-robotic cardiac surgery in which surgical epicardial leads could not be placed. No failure-to-pace events were encountered and patients were able to participate in various levels of physical activity without limitation.

Recommended Citation

Goldhammer, Jordan E; Linganna, Regina E; Pfeil, Douglas S; Witzeling, Scott D; Vishnevsky, Alec; Ruggiero, Nicholas; and Guy, T. Sloane, "Innovative Use of Biotrace Tempo Pacemaker Lead Following Cardiac Surgery" (2022). Department of Anesthesiology Faculty Papers. Paper 81.
https://jdc.jefferson.edu/anfp/81

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.

PubMed ID

35799570

Language

English